Unspecified urinary incontinence
Conditions
Interventions
Group Laser- 36 women with stress urinary incontinence (SUI) will receive a intravaginal CO2 LASER treatment once a month for 3 months, plus behavioral orientation and will also be advised to perform
Sponsors
Escola Paulista de Medicina
Eligibility
Sex/Gender
Female
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: Age between 30 and 75 years; main clinical complaint of stress incontinence urinary confirmed by clinical examination; absence of genital prolapse or prolapse stage more than II, where the prolapse reaches the maximum of the himenal ring and point Ba less than or equal to zero; no use of local estrogen therapy for at least 6 months; negative culture of urine; absence of previous surgical treatment of SUI or colpoplasty; absence of predominant urgency symptom; absence of active infection by HPV or genital herpes; absence of abnormal genital bleeding; absence of antecedent of genital neoplasia or current genital neoplasia; absence of Neurogenic Bladder; absence of pregnancy or puerperium
Exclusion criteria
Exclusion criteria: Age below 30 years and above 75 years; presence of genital prolapse grade 2 that exceeds himenal ring, or grades 3 and 4; previous surgical treatment for stress incontinence urinary; overactive bladder; neurogenic bladder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjective improvement of SUI, defined by a score 4 and 5 of Likert scale, at 15 months after the beginning of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Objective cure of SUI defined as negative stress-test, negative pad-test and absence of report of urinary leakage in the 7 days voiding diary, at 15 months after the beginning of treatment;Evaluation of frequency of urinary loss in sexual intercourse, at 15 months after the beginning of treatment;Evaluation of frequency of urgency and noturna, at 15 months after the beginning of treatment;Determination of lasting of objective cure and subjective improvement of SUI, after treatment, by semestral follow-up with stress test, 1h pad-test, voiding diary, LIKERT Scale, quality of life questionnaires ( ICIQ-SF, IQoL, FSF-I). | — |
Countries
Brazil
Contacts
Public ContactAna Silvia Seki
Universidade Federal do Estado de São Paulo
Outcome results
None listed